Autologous Stem Cell & Non-stem Cell Therapies Market expected to hit $22.2 billion by 2029
The report "Autologous Stem Cell & Non-stem Cell Therapies Market by Type (CAR-T, Tumor Infiltrating Lymphocyte), Indication (Cancer, Musculoskeletal, Dermatology), Source (T-Cells, Mesenchymal Stem Cell), End User (Hospital) - Global Forecast to 2029", is projected to reach USD 22.2 billion by 2029 from USD 5.5 billion in 2024, at a CAGR of 32.3% during the forecast period. One of the key factors driving the market growth is the growing regulatory approvals for autologous...